AGN - Allergan Plc - Insider Stock Trading - OpenInsider

19 results - M - W - D

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	3	5	-0	1	-2	11	-9	-13	-2
P	%wins				40	40	20	80	0	0	30

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/7/19 15:19	3/7/19	AGN	Health	Drug	Pharmaceutical Preparations	Saunders Brent L	L2	DO	CB,P,CEO	P	253	143.67	0	2	1	171	D
11/19/18 19:22	11/16/18	AGN	Health	Drug	Pharmaceutical Preparations	Walsh Matthew M	L2	O	EVP,CFO	P	157	157.00	0	1	4	26	D
9/7/18 08:31	9/6/18	AGN	Health	Drug	Pharmaceutical Preparations	Coughlin Christopher J		D		P	1,906	190.64	0	10	155	16	D
9/4/18 17:07	8/30/18	AGN	Health	Drug	Pharmaceutical Preparations	Freyman Thomas C	L2	D		P	210	190.69	0	1	71	3	D
9/4/18 17:06	8/30/18	AGN	Health	Drug	Pharmaceutical Preparations	Boccuzi Joseph H	L2	D		P	172	190.59	0	1	30	4	D
3/19/18 09:36	3/15/18	AGN	Health	Drug	Pharmaceutical Preparations	Hilado Maria Teresa	L2	O	EVP	P	150	167.39	0	1	3	27	D
3/9/18 16:31	3/5/18	AGN	Health	Drug	Pharmaceutical Preparations	Boccuzi Joseph H	L2	D		P	129	143.42	0	1	160	1	D
3/8/18 10:44	3/8/18	AGN	Health	Drug	Pharmaceutical Preparations	Walsh Matthew M	L2	O	EVP,CFO	P	154	153.96	0	1	4	25	D
3/8/18 10:25	3/8/18	AGN	Health	Drug	Pharmaceutical Preparations	Saunders Brent L	L2	DO	CB,P,CEO	P	503	152.53	0	3	2	181	D
2/22/18 16:25	2/21/18	AGN	Health	Drug	Pharmaceutical Preparations	Walsh Matthew M	L2	O	EVP,CFO	P.d	322	160.94	0	2	9	24	D
12/7/17 17:21	12/7/17	AGN	Health	Drug	Pharmaceutical Preparations	Bodine Chris W	L2	D		P	499	164.77	0	3	22	17	D
12/6/17 12:31	12/6/17	AGN	Health	Drug	Pharmaceutical Preparations	Saunders Brent L	L2	DO	CB,P,CEO	P	758	164.74	0	5	3	186	D
12/5/17 16:16	12/5/17	AGN	Health	Drug	Pharmaceutical Preparations	Coughlin Christopher J		D		P	1,633	163.30	0	10	225	14	D
9/18/17 20:49	3/29/17	AGN	Health	Drug	Pharmaceutical Preparations	Saunders Brent L	L2	DO	CB,P,CEO	P.m	21	239.04	0	0	0	131	D
11/21/16 16:03	11/21/16	AGN	Health	Drug	Pharmaceutical Preparations	Saunders Brent L	L2	DO	CEO,P	P	993	189.13	33	5	5	107	D	-28	-37	-15	-24	-21	-8	-10	-2	-1	-1	0	29
11/15/16 17:18	11/11/16	AGN	Health	Drug	Pharmaceutical Preparations	Hilado Maria Teresa	L2	O	CFO	P	300	210.64	33	1	12	13	D	-16	-33	-11	-20	-14	-10	7	-5	0	-3	-2	26
6/6/16 17:32	6/2/16	AGN	Health	Drug	Pharmaceutical Preparations	Hilado Maria Teresa	L2	O	CFO	P	160	241.57	33	1	6	12	D	17	-19	-22	-14	8	11	8	5	1	-3	-5	-4	-23
8/24/15 18:29	8/21/15	AGN	Health	Drug	Pharmaceutical Preparations	Saunders Brent L	L2	DO	CEO,P	P	302	301.94	33	1	1	133	D	124	32	2	-1	-6	-11	-5	-7	-1	5	-2	3	-2	-13
8/24/15 18:28	8/24/15	AGN	Health	Drug	Pharmaceutical Preparations	Bisaro Paul	L2	DO	Exec CB	P	297	297.42	33	1	0	422	D	124	32	2	-1	-6	-11	-5	-7	-1	5	-2	3	-2	-13

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact